600
Participants
Start Date
May 15, 2024
Primary Completion Date
June 14, 2026
Study Completion Date
September 14, 2026
Emetine Hydrochloride
To administer Emetine Hydrochloride 6mg orally for 10 consecutive days to evaluate the efficacy and safety of emetine for symptomatic Covid-19 patients.
Placebo
Participant takes a placebo for 10 consecutive days.
NOT_YET_RECRUITING
Johns Hopkins University, Division of Infectious Diseases, Baltimore
RECRUITING
Bharatpur Hospital, Bharatpur
Nepal Health Research Council
OTHER_GOV
Bharatpur Hospital Chitwan
UNKNOWN
Stony Brook University
OTHER
Rutgers University
OTHER
Johns Hopkins University
OTHER